RxDoctor Payments Data

Gina Sizemore, PA

Physician Assistant · Romney, WVNPI 1417175456

Payments from drug & device makers

$1,108in general payments, 2019–2025

Across 66 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$237
  • AstraZeneca$216
  • Lilly USA, LLC$176
  • AbbVie$140
  • Boehringer Ingelheim$60
  • E.r. Squibb & Sons, L.L.C.$56
  • plus $223 from 9 others

What the payments were for

  • Food & beverage$1,09699%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,108 in reported general payments places this provider in the 75th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$42,947
Medicare patients
121
Services billed
1,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide173$184,099
MounjaroTirzepatide58$56,952
RybelsusSemaglutide45$51,639
FarxigaDapagliflozin Propanediol34$42,943
JardianceEmpagliflozin18$31,796
EliquisApixaban35$30,485
LinzessLinaclotide18$15,574
JanuviaSitagliptin Phosphate22$7,082
MyrbetriqMirabegron13$5,498
Gabapentin210$3,434
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$2,730
Levothyroxine Sodium272$2,539
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,146
Omeprazole202$1,993
Potassium Chloride131$1,813

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$237$235,738218 claims
Lilly USA, LLCMounjaro$176$56,95258 claims
AstraZenecaFarxiga$216$42,94334 claims
Boehringer IngelheimJardiance$60$31,79618 claims
PfizerEliquis$34$30,48535 claims
AbbVieLinzess$140$15,57418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Romney

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →